Drug-induced pseudotumor cerebri

Clinical Neuropharmacology

Volumn 26, Issue 5, 2003, Pages 236-238

  Salah Uddin, A B M ^a,b  

^a NEW JERSEY NEUROSCIENCE INSTITUTE   (United States)

^b SETON HALL UNIVERSITY   (United States)

Author keywords

Divalproate; PTC (pseudotumor cerebri); Topiramate; Visual loss

Indexed keywords

ACETAZOLAMIDE; FUROSEMIDE; PARACETAMOL; RETINOL; STEROID; TETRACYCLINE DERIVATIVE; TOPIRAMATE; VALPROATE SEMISODIUM;

ADULT; ARTICLE; BRAIN PSEUDOTUMOR; CASE REPORT; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; HUMAN; LONG TERM CARE; LUMBAR PUNCTURE; MALE; MOOD DISORDER; PRIORITY JOURNAL; RETINOL INTOXICATION; SEIZURE; VASCULAR HEADACHE; VISUAL DISORDER; VISUAL IMPAIRMENT; WEIGHT GAIN;

ADULT; HUMANS; MALE; PSEUDOTUMOR CEREBRI; VALPROIC ACID;

EID: 0141644135     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-200309000-00007     Document Type: Article

References (24)

1. Quincke H. Üeber Meningitis serosa und verwandte Zustände. Dtsch Z Nervenheilk. 1897;149-168.
2. Duncan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol. 1988; 45:675-677.
3. Kesler A, Gadoth N. Epidemiology of idiopathic intracranial hypertension in Israel. J Neuroophthalmol. 2001;Mar:21(1):12-4.
4. Digre KB. Idiopathic Intracranial Hypertension Headache. Curr Pain Headache Rep. 2002;6:217-225.
5. Digre KB, Corbett JJ. Pseudotumor cerebri in men. Arch Neurol. 1988;45:866-872.
6. Griffin JP. A review of the literature on benign intracranial hypertension associated with medication. Adverse Drug React Toxicol Rev. 1992;11:41-58.
7. Spector RH, Carlisle J. Pseudotumor cerebri caused by a synthetic vitamin A preparation. Neurology. 1984;34:1509-1511.
8. Roytman M, Frumkin A, Bohn TG. Pseudotumor cerebri caused by isotretinoin. Cutis. 1988;42:399-400.
9. Ang ER, Zimmerman JC, Malkin E. Pseudotumor cerebri secondary to minocycline intake. J Am Board Fam Pract. 2002;May-Jun: 15(3):229-33
10. Quinn AG, Singer SB, Buncic JR. Pediatric tetracycline induced pseudotumor cerebri. J AAPOS. 1999;Feb:3(1):53-57
11. Liu GT, Kay MD, Bienfang DC, et al. Pseudotumor cerebri associated with corticosteroid withdrawal in inflammatory bowel disease. Am J Ophthalmol. 1994;117(3):352-357.
12. Giuseffi V, Wall M, Seigel PZ, et al. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri). A case-controlled study. Neurology. 1991;41:239-244.
13. Aguilera PA, Escamilla SF, Rodriguez Hurtado FJ. Unilateral papilledema in pseudotumor cerebri. Arch Soc Esp Oftalmol. 2001;Sep: 76(9):567-570
14. Nicolle MH, Chatard P. Decompensation of intracranial hypertension by sodium valproate, Apropos of a case. Therapie. 1981; Mar-Apr: 36(2):200-201
15. Tomsak RI, Niffenegger AS, Remler BF. Treatment of pseudotumor cerebri with Diamox (acetazolamide). J Clin Neurol Ophthalmol. 1988;8:93-98.
16. Schoeman JF. Childhood pseudotumor cerebri: clinical and intracranial pressure response to acetazolamide and furosemide treatment in a case series. J Child Neurol. 1994; Apr: 9 (2): 130-134
17. Sugerman HJ, Felton WL. 111, Salvant JB, et al, Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity. Neurology. 1995;45:1655-1659.
18. Herzau V, Baykal HE. Long-term outcome of optic nerve sheath fenestration in pseudotumor cerebri. Klin Monatsbl Auguenheilkd. 1998;Sep:213(3):154-160
19. Goh KY, Schatz NJ, Glaser JS. Optic nerve sheath fenestration for pseudotumor cerebri. J Neuroophthalmol. 1997:Jun;17(2):86-91
20. Eggenberger ER, Miller NR, Vitale S. Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology. 1996:Jun;46(6): 1524-1530
21. Biton V, Mirza W, Montouris G, et al. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology. 2001; Jan 23;56(2):172-177
22. Van Ameringen M, Mancini C, Pipe B, et al. Topiramate treatment for SSRI-induced weight gain in anxiety disorders. J Clin Psychiatry. 2002:Nov:63(11);981-984
23. Roy Chengappa KN, Levine J, Rathore D, et al. Long-term effects of topiramate on bipolar mood instability, weight change and glycemic control: a case series. Eur Psychiatry. 2001;Apr:16(3):186-190
24. Pagan FL, Restrepo L, Balish M, et al. A new drug for an old condition. Headache. 2002;July-August:42:695-696.